Last reviewed · How we verify
Extended Antibiotics
Extended Antibiotics is a Small molecule drug developed by Vanderbilt University Medical Center. It is currently FDA-approved. Also known as: trimethoprim/sulfamethoxazole.
Extended Antibiotics is a type of insulin receptor agonist, classified as a protein modality. It is indicated for conditions such as renal transplant, rectal neoplasms, and maxillary deficiency, among others, and is administered through interventions like stool specimen collection and anal swab sampling.
At a glance
| Generic name | Extended Antibiotics |
|---|---|
| Also known as | trimethoprim/sulfamethoxazole |
| Sponsor | Vanderbilt University Medical Center |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity (PHASE2, PHASE3)
- FuKe Qianjin Capsule Plus Antibiotics for Chronic Endometritis (PHASE4)
- Fluorescence Guided Laparoscopic-Endoscopic Cooperative Sentinel Lymph Node Navigation Surgery Strategy for Early Gastric Cancer (NA)
- Antibiotyping and Prevalence of Virulent Genotypes Among Helicobacter Pylori and Their Impact on Response to Therapy (NA)
- Visual and Patient-Reported Outcomes After Bilateral Non-Diffractive EDOF IOL Implantation (NA)
- A Clinical Trial of Extended (High) Treatment Dose Antibiotics in Combination With Methenamine Hippurate Compared to the Standard of Care (Either Prophylactic (Low) Dose Antibiotic Treatment or Methenamine Hippurate) in Females With Chronic Urinary Tract Infection (PHASE2)
- A Pragmatic Clinical Trial Comparing the Risk of Acute Kidney Injury During Treatment With Vancomycin and Piperacillin-Tazobactam vs. Vancomycin and Cefepime in Hospitalized Patients (PHASE4)
- Shorter Versus Extended Course of Antibiotic Therapy for Necrotizing Soft Tissue Infections
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Extended Antibiotics CI brief — competitive landscape report
- Extended Antibiotics updates RSS · CI watch RSS
- Vanderbilt University Medical Center portfolio CI
Frequently asked questions about Extended Antibiotics
What is Extended Antibiotics?
Who makes Extended Antibiotics?
Is Extended Antibiotics also known as anything else?
What development phase is Extended Antibiotics in?
Related
- Manufacturer: Vanderbilt University Medical Center — full pipeline
- Also known as: trimethoprim/sulfamethoxazole
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing